• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDECATH; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDECATH; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Catalog Number RF-WE14010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 06/17/2020
Event Type  Injury  
Manufacturer Narrative
Udi: not required for product code.Implanted date: device was not implanted.Explanted date: device was not explanted.510(k): k915414.(b)(4).The involved device was not returned for evaluation.Therefore, the investigation was based on user facility information and evaluation of the retention sample.Visual inspection of the retention sample from the involved product code/lot# combination revealed that the were no anomalies, including a kink or crush, over the entire length.The outer and inner diameter were measured and confirmed to meet the manufacturer specifications.The tapered part of the two-way stopcock was measured, and no anomaly was observed.A review of the device history record and shipping inspection records of the involved product code/lot# combination was conducted with no findings.The investigation results verified that the retention sample was normal product.However, with no device return the exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported the involved radifocus glidecath and a predura three-way stopcock (top) were used for cerebral angiography.The procedure was performed in the usual way and finished without any problem.After the procedure was finished, the patient had anomaly and developed aphasia.The possibility cannot be ruled out that aphasia had developed before the procedure.At the time of pre-procedure id check, the patient could not respond verbally to the questions, and responded by nodding.The procedure was completed successfully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIFOCUS GLIDECATH
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
theresa mussaw
reg. no. 2243441
950 elkton blvd
elkton, md 
2837866718
MDR Report Key10269762
MDR Text Key202233843
Report Number9681834-2020-00128
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K090040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2022
Device Catalogue NumberRF-WE14010
Device Lot Number190107
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/17/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/07/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-